[1]刘 宁,徐夏荫.钆塞酸二钠增强MRI中动脉减影图像诊断肝细胞癌的价值[J].医学信息,2023,36(08):74-79.[doi:10.3969/j.issn.1006-1959.2023.08.015]
 LIU Ning,XU Xia-yin.Value of Arterial Subtraction Images in Gadoxetate Disodium-enhanced MRI in the Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2023,36(08):74-79.[doi:10.3969/j.issn.1006-1959.2023.08.015]
点击复制

钆塞酸二钠增强MRI中动脉减影图像诊断肝细胞癌的价值()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年08期
页码:
74-79
栏目:
论著
出版日期:
2023-04-15

文章信息/Info

Title:
Value of Arterial Subtraction Images in Gadoxetate Disodium-enhanced MRI in the Diagnosis of Hepatocellular Carcinoma
文章编号:
1006-1959(2023)08-0074-06
作者:
刘 宁徐夏荫
(1.山东第一医科大学研究生院,山东 济南 250117;2.菏泽市立医院磁共振室,山东 菏泽 274031)
Author(s):
LIU NingXU Xia-yin
(1.Graduate School of Shandong First Medical University,Jinan 250117,Shandong,China;2.Magnetic Resonance Room of Heze Municipal Hospital,Heze 274031,Shandong,China)
关键词:
肝细胞癌磁共振成像动脉减影图像
Keywords:
Hepatocellular carcinomaMagnetic resonance imagingArtery subtraction image
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2023.08.015
文献标志码:
A
摘要:
目的 探究钆塞酸二钠增强MRI中动脉减影图像诊断肝细胞癌(HCC)的价值。方法 回顾性分析2020年6月-2022年6月在菏泽市立医院接受钆塞酸二钠增强MRI检查的97例患者临床资料。比较不同结节病种、结节平扫T1WI信号间动脉期图像与动脉减影图像Nonrim APH检出率以及动脉图像与减影图像对LR-5分类的敏感性和特异性,并评估动脉减影图像在LI-RADS诊断HCC中的价值。结果 排除2例不符合图像要求的患者,共124个结节,包括81个HCC、20个其他恶性肿瘤、23个良性结节。动脉减影图像Nonrim APHE检出率为70.97%,高于动脉期图像的53.23%,差异有统计学意义(P<0.05)。在亚组分析中,HCC动脉减影图像Nonrim APHE检出率高于动脉期图像,差异有统计学意义(P<0.05),而非HCC恶性肿瘤和良性结节动脉期图像与动脉减影图像Nonrim APHE检出率比较,差异无统计学意义(P>0.05);T1WI低信号和T1WI等高信号动脉减影图像Nonrim APHE检出率均高于动脉期图像,差异有统计学意义(P<0.05)。当LR-5被视为HCC时,动脉减影图像诊断HCC的敏感性较动脉期图像增加(P<0.05),而特异性降低,但差异无统计学意义(P>0.05);当LR-4和LR-5均被视为HCC时,动脉期图像和动脉减影图像敏感性和特异性比较,差异无统计学意义(P>0.05)。结论 动脉减影图像可提高钆塞酸二钠增强MRI对Nonrim APHE的检出率。当应用LI-RADS诊断HCC时,动脉减影图像可提高灵敏度,而不会降低特异性。
Abstract:
Objective To explore the value of arterial subtraction images in gadoxetate disodium-enhanced MRI in the diagnosis of hepatocellular carcinoma.Methods The clinical data of 97 patients who underwent gadoxetate disodium-enhanced MRI in Heze Municipal Hospital from June 2020 to June 2022 were retrospectively analyzed. The detection rate of Nonrim APH in arterial phase images and arterial subtraction images between T1WI signals of different sarcoidosis types and nodules, the sensitivity and specificity of arterial images and subtraction images for LR-5 classification were compared, and the value of arterial subtraction images in LI-RADS diagnosis of HCC was evaluated.Results Excluding 2 patients who did not meet the image requirements, a total of 124 nodules, including 81 HCC, 20 other malignant tumors, and 23 benign nodules. The detection rate of Nonrim APHE in arterial subtraction images was 70.97%, which was higher than 53.23% in arterial phase images (P<0.05). In the subgroup analysis, the detection rate of Nonrim APHE in HCC arterial subtraction images was higher than that in arterial phase images, and the difference was statistically significant (P<0.05). There was no significant difference in the detection rate of Nonrim APHE between arterial phase images and arterial subtraction images of non-HCC malignant tumors and benign nodules (P>0.05). The detection rate of Nonrim APHE in arterial subtraction images of T1WI low signal and T1WI equal high signal was higher than that in arterial phase images, and the difference was statistically significant (P<0.05). When LR-5 was considered as HCC, the sensitivity of arterial subtraction imaging in the diagnosis of HCC was higher than that of arterial phase imaging (P<0.05), while the specificity was lower, but the difference was not statistically significant (P>0.05). When LR-4 and LR-5 were regarded as HCC, there was no significant difference in sensitivity and specificity between arterial phase image and arterial subtraction image (P>0.05).Conclusion Arterial subtraction images can improve the detection rate of nonrim APHE by gadoxetate disodium-enhanced MRI. When LI-RADS is used to diagnose HCC, arterial subtraction images can improve sensitivity without reducing specificity.

参考文献/References:

[1]Zheng R,Zhang S,Zeng H,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.[2]Chernyak V,Fowler KJ,Kamaya A,et al.Liver Imaging Reporting and Data System (LI-RADS) version 2018:imaging of hepatocellular carcinoma in at-risk patients[J].Radiology,2018,289(3):816-830.[3]Marrero JA,Kulik LM,Sirlin CB,et al.Diagnosis,Staging,and Management of Hepatocellular Carcinoma:2018 Practice Guidance by the American Association for the Study of Liver Diseases[J].Hepatology,2018,68(2):723-750.[4]Galle PR,Forner A,Llovet JM,et al.EASL clinical practice guidelines:management of hepatocellular carcinoma[J].Journal of Hepatology,2018,69(1):182-236.[5]Ebara M,Fukuda H,Kojima Y,et al.Small hepatocellular carcinoma:relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma[J].Radiology,1999,210(1):81-88.[6]Tirkes T,Mehta P,Aisen AM,et al.Comparison of Dynamic Phase Enhancement of Hepatocellular Carcinoma Using Gadoxetate Disodium vs GadobenateDimeglumine[J].J Comput Assist Tomogr,2015,39(4):479-482.[7]Vernuccio F,Bruno A,Costanzo V,et al.Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA[J].Curr Probl Diagn Radiol,2020,49(6):398-403.[8]Kim SY,Wu EH,Park SH,et al.Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent[J].Abdominal Radiology,2016,41:1522-1531.[9]Kim DH,Choi SH,Byun JH,et al.Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma[J].J Hepatol,2019,71(3):534-542.[10]Hong SB,Hong S,Choi SH,et al.Multiple arterial-phase MRI with gadoxetic acid improves diagnosis of hepatocellular carcinoma ≤3.0 cm[J].Liver Int,2023,43(2):462-470.[11]Joo I,Lee JM,Lee DH,et al.Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI:can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?[J].Eur Radiol,2019,29(4):1724-1732.[12]Pan J,Li W,Gu L,et al.Performance of adding hepatobiliary phase image in magnetic resonance imaging for detection of hepatocellular carcinoma:a meta-analysis[J].Eur Radiol,2022,32(11):7883-7895.[13]Lee YJ,Lee JM,Lee JS,et al.Hepatocellular carcinoma:diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis[J].Radiology,2015,275(1):97-109.[14]An C,Park MS,Kim D,et al.Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma[J].Eur Radiol,2013,23(4):924-930.[15]郭然,武明辉,宁培钢,等.基于减影技术钆塞酸二钠增强MRI评估肝脏影像报告和数据系统主要征象的价值[J].中华放射学杂志,2021,55(11):1184-1190.[16]Choi SH,Kim SY,Lee SS,et al.Subtraction Images of Gadoxetic Acid-Enhanced MRI:Effect on the Diagnostic Performance for Focal Hepatic Lesions in Patients at Risk for Hepatocellular Carcinoma[J].AJR Am J Roentgenol,2017,209(3):584-591.[17]Cerny M,Bergeron C,Billiard JS,et al.LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma:Performance of Major and Ancillary Features[J].Radiology,2018,288(1):118-128.[18]Jeon SK,Joo I,Lee DH,et al.Combined hepatocellular cholangiocarcinoma:LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging[J].Eur Radiol,2019,29(1):373-382.[19]Park SH,Lee SS,Yu E,et al.Combined hepatocellular-cholangiocarcinoma:Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis[J].J Magn Reson Imaging,2017,46(1):267-280.[20]Fujita N,Asayama Y,Nishie A,et al.Mass-forming intrahepatic cholangiocarcinoma:Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings[J].Eur Radiol,2017,27(2):498-506.[21]刘斌,陈枫,宋文艳,等.临床和影像特征在硬化型肝癌精准诊断中价值[J].中华实用诊断与治疗杂志,2021,35(4):405-407.

相似文献/References:

[1]雷少晖,张永海.脑氧代谢的影像学测定方法研究[J].医学信息,2018,31(05):38.[doi:10.3969/j.issn.1006-1959.2018.05.015]
 LEI Shao-hui,ZHANG Yong-hai.Imaging Study of Brain Oxygen Metabolism[J].Journal of Medical Information,2018,31(08):38.[doi:10.3969/j.issn.1006-1959.2018.05.015]
[2]管海生.膝关节剥脱性骨软骨炎MRI诊断[J].医学信息,2018,31(06):158.[doi:10.3969/j.issn.1006-1959.2018.06.056]
 GUAN Hai-sheng.MRI Diagnosis of Exfoliative Osteochondritis in Knee Joint[J].Journal of Medical Information,2018,31(08):158.[doi:10.3969/j.issn.1006-1959.2018.06.056]
[3]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及 肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
 WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(08):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[4]刘 钢,李志伟,田 晞,等.磁共振检查对冯·希佩尔·林道综合征诊断的意义[J].医学信息,2018,31(18):145.[doi:10.3969/j.issn.1006-1959.2018.18.047]
 LIU Gang,LI Zhi-wei,TIAN Xi,et al.The Significance of Magnetic Resonance Examination in the Diagnosis of Von Hippel-Lindau Disease[J].Journal of Medical Information,2018,31(08):145.[doi:10.3969/j.issn.1006-1959.2018.18.047]
[5]马平平,程宇琪,许秀峰,等.抑郁症脑磁共振成像与抗抑郁治疗临床改善间关系的研究进展[J].医学信息,2018,31(24):31.[doi:10.3969/j.issn.1006-1959.2018.24.009]
 MA Ping-ping,CHENG Yu-qi,XU Xiu-feng,et al.Advances in Research on the Relationship between Brain Magnetic Resonance Imaging and Clinical Improvement of Antidepressant Therapy[J].Journal of Medical Information,2018,31(08):31.[doi:10.3969/j.issn.1006-1959.2018.24.009]
[6]刘姗灵,冉 冉,涂 刚.乳腺Paget′s 病诊断与治疗相关研究进展[J].医学信息,2019,32(07):1.[doi:10.3969/j.issn.1006-1959.2019.07.001]
 LIU Shan-ling,RAN Ran,TU Gang.Advances in Research on Diagnosis and Treatment of Paget's Disease in Breast[J].Journal of Medical Information,2019,32(08):1.[doi:10.3969/j.issn.1006-1959.2019.07.001]
[7]蔡 彬,黄 伟,储正达,等.直肠腔内超声与相控阵线圈磁共振在直肠癌术前局部分期中的Meta分析[J].医学信息,2019,32(10):70.[doi:10.3969/j.issn.1006-1959.2019.10.024]
 CAI Bin,HUANG Wei,CHU Zheng-da,et al.Meta-analysis of Intra-rectal Ultrasound and Phased-array Magnetic Resonance in the Preoperative Partial Phase of Rectal Cancer[J].Journal of Medical Information,2019,32(08):70.[doi:10.3969/j.issn.1006-1959.2019.10.024]
[8]黄亚勇,师毅冰,陈国芳,等.颅内生殖细胞瘤的MRI影像表现及诊断[J].医学信息,2019,32(20):167.[doi:10.3969/j.issn.1006-1959.2019.20.053]
 HUANG Ya-yong,SHI Yi-bing,CHEN Guo-fang,et al.MRI Imaging Findings and Diagnosis of Intracranial Germ Cell Tumor[J].Journal of Medical Information,2019,32(08):167.[doi:10.3969/j.issn.1006-1959.2019.20.053]
[9]王召华,李小虎,钱银锋,等.MRI对胰腺导管内乳头状粘液瘤良恶性的诊断价值[J].医学信息,2019,32(14):166.[doi:10.3969/j.issn.1006-1959.2019.14.056]
 WANG Zhao-hua,LI Xiao-hu,QIAN Yin-feng,et al.Diagnostic Value of MRI for Benign and Malignant Intraductal Papillary Myxoma of the Pancreas[J].Journal of Medical Information,2019,32(08):166.[doi:10.3969/j.issn.1006-1959.2019.14.056]
[10]刘军莲,戴 娜,杨 迎,等.全脊柱MRI对强直性脊柱炎急性炎症的诊断价值[J].医学信息,2019,32(16):167.[doi:10.3969/j.issn.1006-1959.2019.16.057]
 LIU Jun-lian,DAI Na,YANG Ying,et al.Diagnostic Value of Total Spine MRI in Acute Inflammation of Ankylosing Spondylitis[J].Journal of Medical Information,2019,32(08):167.[doi:10.3969/j.issn.1006-1959.2019.16.057]
[11]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
 LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Journal of Medical Information,2022,35(08):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]

更新日期/Last Update: 1900-01-01